Anna Olsson-Brown (@aolssonbrown) 's Twitter Profile
Anna Olsson-Brown

@aolssonbrown

Mum, Medical Oncology Consultant, IO toxicity specialist, CEO IOCN, passion for immunotherapy cancer care, onco-toxicology, realworld research and basset hounds

ID: 4899542776

calendar_today11-02-2016 22:22:32

501 Tweet

1,1K Takipçi

223 Takip Edilen

The Immunobuddies Podcast (@immunobuddies) 's Twitter Profile Photo

🎙️ The final episode of our Personalised Immunotherapy podcast series is here! 📌 Episode 3: The Future Potential Dr. Paolo A. Ascierto returns to discuss what lies ahead for personalised immunotherapy and its transformative possibilities in cancer care. 🔗 Listen to the full series

Ollie Minton (@drol007) 's Twitter Profile Photo

My Clinical Outcomes Ethan Basch Nature Medicine EORTC Quality of Life Group (QLG) EORTC Anna Olsson-Brown “These findings demonstrate that symptom monitoring with PRO meaningfully improves clinical outcomes, the patient experience and utilization of services and should be included as a standard part of quality cancer clinical care”

Rafeh Naqash, MD (@thenasheffect) 's Twitter Profile Photo

Labour of love for 2 years now published in Clinical Lung Cancer. Largest study on clinical and tumor immunophenotypic characteristics in older adults with NSCLC and PDL1>50. Phenomenal work by Biagio Ricciuti, MD PhD João Alessi, MD Valentina Santo Adriana Barrichello, MD to take this to finish line!

Labour of love for 2 years now published in <a href="/ClinicalLung/">Clinical Lung Cancer</a>. Largest study on clinical and tumor immunophenotypic characteristics in older adults with NSCLC and PDL1&gt;50. Phenomenal work by <a href="/BiagioRicciutMD/">Biagio Ricciuti, MD PhD</a> <a href="/alessi_joao/">João Alessi, MD</a> <a href="/valentsant/">Valentina Santo</a> <a href="/BarrichelloMd/">Adriana Barrichello, MD</a> to take this to finish line!
Practical Neurology (@practicalneurol) 's Twitter Profile Photo

Diagnosis and management of immune checkpoint inhibitor neurotoxicity requires close collaboration between oncologists, neurologists and other health care professionals. @freddievonberg Anna Olsson-Brown Heather Shaw NEONeurotox

Diagnosis and management of immune checkpoint inhibitor neurotoxicity requires close collaboration between oncologists, neurologists and other health care professionals.
@freddievonberg <a href="/AOlssonBrown/">Anna Olsson-Brown</a> <a href="/DrHMShaw/">Heather Shaw</a> <a href="/NEONeurotox/">NEONeurotox</a>
Melanoma Focus UK (@focusonmelanoma) 's Twitter Profile Photo

📣 Registration is now open for this year's Melanoma Focus Healthcare Professional Virtual Meeting! 📆 Friday 16th May 2025 📝 Organised by Dr Anna Olsson-Brown (Anna Olsson-Brown) 🐦 Early bird rate ends: April 21st 2025 Register: buff.ly/42LTu76 #VRM2025

📣 Registration is now open for this year's Melanoma Focus Healthcare Professional Virtual Meeting!  

📆 Friday 16th May 2025 
📝 Organised by Dr Anna Olsson-Brown (<a href="/AOlssonBrown/">Anna Olsson-Brown</a>)
🐦 Early bird rate ends: April 21st 2025  

Register: buff.ly/42LTu76 #VRM2025
Jarushka Naidoo (@drjnaidoo) 's Twitter Profile Photo

Rapid CNS Response from Tarlatamab in pts with ES SCLC & untreated BM JTO & JTO CRR: - 10 pt case series, relapsed SCLC - response/SD in 9/10 pts (incl. LMD) - tarlatamab had CNS activity in pts with up to 20BM, avoiding WBRT OncoAlert Lauren Averett Byers, MD #LCSM jto.org/article/S1556-…

The Immunobuddies Podcast (@immunobuddies) 's Twitter Profile Photo

🎙️ New #ImmunoBuddies Episode Out Now! "Immunotherapy Reimagined – The Misnomer of Cancer Vaccines" 🧬💉 Is it a vaccine? A treatment? Or both? Join us as we unpack the terminology and science behind the fascinating field of cancer vaccines. Explore how we use this in real life

🎙️ New #ImmunoBuddies Episode Out Now!
 "Immunotherapy Reimagined – The Misnomer of Cancer Vaccines" 🧬💉
Is it a vaccine? A treatment? Or both? Join us as we unpack the terminology and science behind the fascinating  field of cancer vaccines. Explore how we use this in real life
The Immunobuddies Podcast (@immunobuddies) 's Twitter Profile Photo

🎙️ Throwback Thursday: Immunobuddies Podcast Highlight from November 2023! 🎇 🧡 Managing Immunotherapy in Organ Transplant Patients 🧡 📍 Featuring: Dr. Glenn Hanna Associate Professor, Harvard Medical School Dana-Farber Cancer Institute, Boston 🩺 A 2-part deep dive into: ✅

🎙️ Throwback Thursday: Immunobuddies Podcast Highlight from November 2023! 🎇
🧡 Managing Immunotherapy in Organ Transplant Patients 🧡

📍 Featuring: Dr. Glenn Hanna
Associate Professor, Harvard Medical School
Dana-Farber Cancer Institute, Boston

🩺 A 2-part deep dive into:

✅
The Immunobuddies Podcast (@immunobuddies) 's Twitter Profile Photo

🎙️ New Episode Alert! ImmunoBuddies Podcast – Episode 143 "Manifest! The Future of Predictive Biomarkers for Treatment Response and Toxicity", Episode 1 of 3 with Zayd Tippu from The Francis Crick Institute What if we could predict how patients will respond to treatment—or even anticipate

🎙️ New Episode Alert!
 ImmunoBuddies Podcast – Episode 143
 "Manifest! The Future of Predictive Biomarkers for Treatment Response and Toxicity", Episode 1 of 3
with <a href="/ZaydTippu/">Zayd Tippu</a>  from <a href="/TheCrick/">The Francis Crick Institute</a> 

What if we could predict how patients will respond to treatment—or even anticipate
Anna Olsson-Brown (@aolssonbrown) 's Twitter Profile Photo

A patient self portrait of the experience of irAEs shown at ASCO-so very powerful and important. Great session on coordinating irAE care and how important it is ⁦-exciting to think we could do this internationally ⁦ASCO⁩ ⁦ASPIRE Community of Practice⁩ ⁦Immuno-Oncology Clinical Network

A patient self portrait of the experience of irAEs shown at ASCO-so very powerful and important. Great session on coordinating irAE care and how important it is ⁦-exciting to think we could do this internationally ⁦<a href="/ASCO/">ASCO</a>⁩ ⁦<a href="/ASPIRE_CoP/">ASPIRE Community of Practice</a>⁩ ⁦<a href="/IOClinicalNet/">Immuno-Oncology Clinical Network</a>⁩
Yakup Ergün (@dr_yakupergun) 's Twitter Profile Photo

Delphi consensus on adjuvant IO and recurrence management in RCC 🔹️Use Leibovich score to select pts for adjuvant pembro 🔹️Start adjuvant tx within 90 days post-surgery 🔹️PD-L1 positivity not required for tx 🔹️ICI-refractory = relapse within 6 mo of adjuvant tx

Delphi consensus on adjuvant IO and recurrence management in RCC

🔹️Use Leibovich score to select pts for adjuvant pembro

🔹️Start adjuvant tx within 90 days post-surgery

🔹️PD-L1 positivity not required for tx

🔹️ICI-refractory = relapse within 6 mo of adjuvant tx
Immuno-Oncology Clinical Network (@ioclinicalnet) 's Twitter Profile Photo

🎫Tickets are now available for the next IOCN Ask a Question Webinar: A Focus on Mucositis. 📅 Tuesday 8th July 2025 🕐18:30 - 20:00 🧠💭Don't forget to submit your questions to us! Register at the link below! ticketsource.co.uk/whats-on/onlin… UKONS UK Acute Oncology Society

The Immunobuddies Podcast (@immunobuddies) 's Twitter Profile Photo

🧬 New Episode – HLH Demystified! 😱 Immunobuddies Podcast | Episode 146 🎧 "Not Another Triad of Doom!" Haemophagocytic lymphohistiocytosis (HLH) may sound terrifying — and yes, it's as intense as it sounds — but we’re here to break it down without the panic. Once you know

🧬 New Episode – HLH Demystified! 😱
 Immunobuddies Podcast | Episode 146
🎧 "Not Another Triad of Doom!"

Haemophagocytic lymphohistiocytosis (HLH) may sound terrifying — and yes, it's as intense as it sounds — but we’re here to break it down without the panic.

Once you know